Vimarsana
Biggest News Aggregation in the World

Page 3 - Analgesic Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Analgesic Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Analgesic Program Today - Breaking & Trending Today

PreveCeutical Medical Inc.: PreveCeutical Awards ICON Analgesic Program (Painkiller) Clinical Development - Vimarsana News

PreveCeutical Medical Inc.: PreveCeutical Awards ICON Analgesic Program (Painkiller) Clinical Development

Vancouver, British Columbia--(Newsfile Corp. - February 7, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that on February

PreveCeutical Medical Inc.: PreveCeutical - Background IP, US Patent Granted Disulfide Bond Containing Compounds - Vimarsana News

PreveCeutical Medical Inc.: PreveCeutical - Background IP, US Patent Granted Disulfide Bond Containing Compounds

Vancouver, British Columbia--(Newsfile Corp. - January 23, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that US patent

PreveCeutical Medical Inc.: PreveCeutical - Dynorphin Peptides (Painkiller) and Uses Thereof Patent Update and Officer Update - Vimarsana News

PreveCeutical Medical Inc.: PreveCeutical - Dynorphin Peptides (Painkiller) and Uses Thereof Patent Update and Officer Update

Vancouver, British Columbia--(Newsfile Corp. - January 17, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that PreveCeutical

PreveCeutical Medical Inc.: PreveCeutical Files Provisional Patent Application for D-Amino Acid Peptides - Vimarsana News

PreveCeutical Medical Inc.: PreveCeutical Files Provisional Patent Application for D-Amino Acid Peptides

Vancouver, British Columbia--(Newsfile Corp. - November 24, 2021) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce it has filed